64.01 USD
▲-0.41+2.81%
盘后 61.02 -1.99%
2026-08-03
市值
$6.19B
市盈率
—
EPS
-4.71
股息率
—
52 周区间
30.65 – 72.66
成交量
639.25K
Beta
0.61
目标价
80.93
52W 低 30.6552W 高 72.66
价格走势
公司简介
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders. Its product candidates include Azetukalner, a novel, potent Kv7 potassium channel opener which is in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. In a...